RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients

Although limited by severe side effects and development of resistance, platinum-based therapies still represent the most common first-line treatment for non-small cell lung cancer (NSCLC). However, a crucial need in the clinical management of NSCLC is represented by the identification of cases sensi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncogene
Hlavní autoři: Tessari, Anna, Parbhoo, Kareesma, Pawlikowski, Meghan, Fassan, Matteo, Rulli, Eliana, Foray, Claudia, Fabbri, Alessandra, Embrione, Valerio, Ganzinelli, Monica, Capece, Marina, Campbell, Moray J., Broggini, Massimo, La Perle, Krista, Farina, Gabriella, Cole, Sara, Marabese, Mirko, Hernandez, Marianna, Amann, Joseph M., Pruneri, Giancarlo, Carbone, David P., Garassino, Marina C., Croce, Carlo M., Palmieri, Dario, Coppola, Vincenzo
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6690599/
https://ncbi.nlm.nih.gov/pubmed/30076413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0424-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky